Evidence map›Paper›PMID 26433589›Full record

ArticleJournal of clinical immunology2015

Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.

Paul E Gray, Tracey A O'Brien, Mayura Wagle, Stuart G Tangye, Umaimainthan Palendira, Tony Roscioli, Sharon Choo, Rosemary Sutton, John B Ziegler, Katie Frith

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Paul E GrayDepartment of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, Australia.
Tracey A O'BrienSchool of Women's and Children's Health, University of New South Wales, Sydney, Australia.
Mayura WagleImmunology and Immunodeficiency Group, Immunology Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.
Stuart G TangyeImmunology and Immunodeficiency Group, Immunology Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.
Umaimainthan PalendiraImmunology and Immunodeficiency Group, Immunology Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.
Tony RoscioliDepartment of Medical Genetics, Sydney Children's Hospital, Randwick, Australia.
Sharon ChooDepartment of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia.
Rosemary SuttonChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Randwick, Australia.
John B ZieglerDepartment of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, Australia.
Katie FrithDepartment of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, Australia. frith.katie@gmail.com.
Sydney Children's Hospital · AUGarvan Institute of Medical Research · AUChildren's Cancer Institute Australia · AURoyal Children's Hospital · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledVasculitis occurs rarely in association with X-linked lymphoproliferative disease (XLP). There are four published cases of non-EBV XLP-associated cerebral vasculitis reported, none of whom have survived without major cognitive impairment. CASE: A 9-year old boy initially presented aged 5 years with a restrictive joint disease. He subsequently developed dysgammaglobulinemia, episodic severe pneumonitis, aplastic anaemia, gastritis and cerebral vasculitis. A diagnosis of XLP was made, based on flow cytometric analysis and the identification of a novel mutation in SH2D1A, c.96G>C. No peripheral blood lymphocyte clonal proliferation was identified and he was EBV negative, although human herpes virus-7 (HHV7) was detected repeatedly in his cerebrospinal fluid. He underwent a reduced intensity unrelated umbilical cord blood transplant, but failed to engraft. A second 5/6 matched cord gave 100 % donor engraftment. Complications included BK virus-associated haemorrhagic cystitis, a possible NK-cell mediated immune reconstitution syndrome and post-transplant anti-glomerular basement membrane disease, the latter treated with cyclophosphamide and rituximab. At +450 days post-transplant he is in remission from his vasculitis and anti-glomerular basement membrane disease, and HHV-7 has remained undetectable.

conclusionThis is the second published description of joint disease in XLP, and only the fourth case of non-EBV associated cerebral vasculitis in XLP, as well as being the first to be successfully treated for this manifestation. This case raises specific questions about vasculitis in XLP, in particular the potential relevance of HHV-7 to the pathogenesis.

Indexed as

Cord Blood Stem Cell TransplantationAustraliaChildCyclophosphamideHerpesvirus 7, HumanHLA AntigensHumansImmunityIntracellular Signaling Peptides and ProteinsJoint DiseasesKiller Cells, NaturalLymphoproliferative DisordersMaleMutation, MissensePedigreePostoperative ComplicationsCyclophosphamideHLA AntigensIntracellular Signaling Peptides and ProteinsRituximabSH2D1A protein, humanSignaling Lymphocytic Activation Molecule Associated Proteinhaematopoietic stem cell transplantHHV-7vasculitisX-linked lymphoproliferative disease (XLP)

Identifiers

PMID26433589
OpenAlexW2140048042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.